Phelan-McDermid Syndrome Affects More Than 45,000 Americans, Major Study Reveals

Major Genetic Disorder Study Expands Understanding

A major analysis published on September 25, 2026 suggests that Phelan-McDermid syndrome, a genetic disorder closely linked to autism, may affect about 1 in 7,300 people. This finding translates to potentially more than 45,000 Americans living with the condition, according to the research.

What is Phelan-McDermid Syndrome?

Phelan-McDermid syndrome is a rare genetic disorder that results from deletions or mutations affecting the SHANK3 gene. The condition is characterized by developmental delays, intellectual disability, autism spectrum features, and other neurological challenges. Many individuals with the disorder experience severe communication difficulties and behavioral challenges.

Underdiagnosis Remains a Critical Concern

Researchers warn that thousands of cases may remain undiagnosed, highlighting a critical gap in medical awareness and diagnostic protocols. The study emphasizes that improved recognition of the syndrome's clinical features could help families access earlier interventions and support services. Many cases are likely missed because symptoms overlap with other developmental disorders, including autism spectrum disorder and cerebral palsy.

Implications for Diagnosis and Care

The research underscores the importance of genetic testing and clinical awareness among healthcare providers. With potentially tens of thousands of unidentified cases in the United States alone, increased screening and education could significantly improve outcomes for affected individuals and their families. The findings support calls for enhanced genetic counseling resources and specialized care pathways for individuals with rare genetic disorders.